A forum moderator shared an abstract discussing the use of SS-31 (Elamipretide) as a potential pharmacotherapy for sarcopenia. The research indicates that while SS-31 shows promising findings in treating progressive muscle mass decline and organ failure, it has not yet received official approval for this indication.